Real-time enrollment status for this leprosy type 2 reaction clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:29 PM UTC
| NCT Number | NCT07172659 |
| Recruiting Status | Recruiting |
| Condition | Leprosy Type 2 Reaction |
| Phase | PHASE2 |
| Target Enrollment | 45 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Medicines Development for Global Health |
| Last Updated on CT.gov | May 26, 2026 (May 26, 2026) |
As of July 17, 2026: Clinical trial NCT07172659 is currently recruiting participants. This phase2 study for leprosy type 2 reaction is actively seeking new participants at 1 location across the United States. The study is sponsored by Medicines Development for Global Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07172659 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07172659 was last updated May 26, 2026 (May 26, 2026). HelloStudys verifies this status automatically.